We used a heterogeneous stock of mice-UM-HET3, the first generation offspring of CByB6F1/J and C3D2F1/J parents-totesteffectsofsixantiagingtreatmentsonlifespan.Inthefirstreportofdietrestrictioninastructured,segregating heterogeneous population, we observed essentially the same increases in mean and maximum life span as found in CByB6F1/Jhybridpositivecontrols.WealsoreportresultsoftreatmentwithN-acetyl-l-cysteinestartedat7months,and aspirin, nitroflurbiprofen, 4-hydroxy phenyl N-tert-butyl nitrone, and nordihydroguaiaretic acid, all started at 16-18 months.OnlymaleUM-HET3micereceivingN-acetyl-l-cysteinehadsignificantlyincreasedlifespan,andthismay havebeenduetotreatment-relatedinadvertentdietrestriction.Theotheragentshadnosignificanteffectsonlifespan. TheuseofUM-HET3micehelpsassurethattheseresultsarenottheresultofunresponsivenessofasinglegenotypebut thattheymorebroadlyrepresentlaboratorymice.
A critical problem in mammalian aging research is overreliance on specific inbred strains of rats and mice (1) .Thepopularityofinbredstrainsiswellearnedavailability,reliability,genetichomogeneity,andthorough characterization-butcomeswithamajorrisk:thepossibilityofgeneralizingstrain-specificidiosyncrasiesastraits ofnormalaging.Thisriskisaparticularconcernforlifespan studiesbecauselifespanisespeciallysusceptibletoinbreedingdepression,whichhasstrain-specificmanifestations and creates experimental confounds with senescence. Numerousapproacheshavebeenusedtoaddressthisissue [reviewedin (2, 3) ].Oftenthebestchoiceistousewelldefinedgeneticallysegregatingstocks,constructeddirectly fromparentalinbredstrainschosenfortheirgeneticdiversity.
CrossingtwodiverseF1hybridsinafour-straincrossisa convenient way to create such a structured segregating heterogeneousmousepopulation.Althougheachindividual is genetically distinct, the population can be reproduced fromthestandardF1hybridparentsatanytime (4) .The UM-HET3 (hereafter called HET3) cross, a specific fourstraincrossthatwasdevelopedbyDr.RichardA.Millerfor thestudyofaging(5),issuchapopulation.Itcomprises thefirstgenerationoffspringofacrossbetweenCByB6F1 femalesandC3D2F1males.Exclusionofshort-livedparental strainshelpsreducethefrequencyofallelesthatinfluence mortalityindependentlyofsenescence.Also,thederivation ofthreeofthesefourstrainsfromcompletelyindependent sources(6)assuresahighdegreeofgeneticdiversity.In fact,althoughthefourstrainsoftheHET3crossrepresent only7%ofthe55domesticatedinbredstrainsoflaboratory miceintheSangerInstitutedatabase(http://www.sanger.ac. uk/Projects/M_musculus/), the genetic diversity is much broader: the 1,937,989 single nucleotide polymorphisms (SNPs) within the HET3 cross represent 35% of the total diversity (5,528,028 SNPs) among all 55 domesticated inbred strains, whichincludes inbred strains developedin Japan, Europe, and the United States. Finally, another advantage of the use of HET3 mice is that the stock has beencharacterizedformanyagingparameters (5, (7) (8) (9) . TheNationalInstituteonAgingusesHET3astheanimal modelforitsInterventionsTestingProgram(ITP),whichtests promising antiaging interventions (7) . The genetic diversity designed into theHET3stock ensures that causesofagerelatedmortalitywillbevaried,andthus,thatanysignificantincreaseinlifespanfromaninterventionwillnotresult merelyfromabeneficialeffectonastrain-specificdisease. To date, the ITP has reported that lifelong treatment with aspirinorwithnordihydroguaiareticacid(NDGA)starting at4monthsofagesignificantlyincreaseslifespaninmale HET3mice (10) ,andthattreatmentwithrapamycinstarted at20monthsofagesubstantiallyincreaseslifespaninboth maleandfemaleHET3mice (11) .Interventionsbeingtested todate,andprocedurestosubmitideasforinterventions totheITP,areprovidedathttp://www.nia.nih.gov/Research Information/ScientificResources/InterventionsTesting Program.htm
The current study further characterizes aging in HET3 miceusingaclassictreatment,dietrestriction(DR).Forthe past 75 years, scientists have known that DR typically increases life span in healthy mouse and rat populations, thus setting the standard for interventions that increase mammalianlifespan (12, 13) .Recently,however,twoDR studies using large collections of the inbred long sleep × inbredshortsleeprecombinantinbredstrainsetproduced fromthesametwoparentalinbredstrains (14, 15) Inaddition,wereportresultsofstudiesusingHET3mice to test the effectiveness of other potential antiaging treatments,includingN-acetyl-l-cysteine(NAC),whichmay retardagingbyseveralmechanisms.NACisasynthetic acetylatedderivativeofcysteine,hasalonghistoryofclinical use, and appears to be well tolerated by humans.The majormetabolitesofNACareL-cysteineandglutathione. NAC, like endogenous thiols, is an effective scavenger of freeradicals,andisconsideredanantioxidant (16) .Consequently,NAChasbeentestedasapotentialauxiliarytreatmentincardiovasculardisease,pulmonaryfibrosis,arthritic jointinflammation,HIVinfection,renalfailure,andcancer (17) (18) (19) (20) (21) (22) .Recently,Ackert-Bicknelletal.(23)haveshown thatchronicNACtreatmentinmicecansuppresslevels ofcirculatinginsulin-likegrowthfactor-1by20%-50%, dependingonmousestrain.Therefore,NACmayretard senescencethroughbothantioxidantandgrowth-retarding mechanisms.
Wealsoreportstudiesofaspirin,nitroflurbiprofen(NFP), 4-hydroxy phenyl N-tert-butyl nitrone (4-OH-PBN), and NDGA,previouslytestedinHET3micestartingat4months ofage (7, 10) .Thecurrentstudystartedtreatmentwhenthe HET3femalesreached16-18months(equivalenttoabout 55yearsinhumans)totestthehypothesisthattheseinterventionsmightbemoreeffectiveifinitiatedatlatemiddle age-specifically,todeterminewhethereffectsofagingor treatment duration might alter the response to treatment such that treatment initiated in older mice may be more effective(seeDiscussion).Thesetreatmentswerechosen basedontheirantioxidantactivityoranti-inflammatory activityorboth[discussedin (7, 10) ].
OurresultssupporttheuseofHET3miceinstudiesof agingforthefollowingreasons:HET3micearegenetically well defined. They respond well to DR.And their use in intervention studies helps assure that both negative and positive findings are broadly applicable-that the results aredependentneither oninbreedingdepressionnoronan idiosyncraticresponseofaspecificgenotype.
Methods

Mice
The HET3 mice used in the current study were producedbyacrossbetweentwodifferentF1parentsfromThe JacksonLaboratory:(BALB/cByJ×C57BL/6J)F1mothers (CByB6F1/J; JAX Mice stock #100009) and (C3H/HeJ × DBA/2J)F1fathers(C3D2F1/J;JAXMicestock#100004 
NAC (Sigma #A7250
).-Startingat7monthsofage,mice weregivendrinkingwatercontainingeither5g/LofNAC (lo-NAC;predictedatthestartofthestudytoachieveabout 600mg/kg/dofNAC)or10g/LofNAC(hi-NAC;predicted atthestartofthestudytoachieveabout1,200mg/kg/dof NAC).Treatedwaterwaspreparedfresheachweek.
Webasedourdosageonthefollowing:NACsupplementationat250mg/kg/dincreasedlifespaninamousemodel oflupus (24) .Inresponseto1,200mg/kg/d(ourhi-NAC dose)ingrowingmice,seruminsulin-likegrowthfactor-1 levelsweresuppressedby20%-50%,dependingonstrain, which was sufficient to diminish long bone growth and bonemineraldensity (23) .Importantly,atthishi-NACdose, foodintakeremainedatnormallevels(3gpermouseper day).Therefore,wechosea"high"doseofNAC (1, (7)andwere checkedagainstpublishedliteraturetobecertainthatthey producednotoxicity.Therationalefortestingtheseinterventionsandresultsoftestingstartingat4monthshasbeen published (7, 10) . Concentrations of these compounds, based on weight ratios, are reported in the following (assumingmiceweighed30gandate5goffoodperday):
Aspirinwasaddedtochowat21mg/kgfoodtoproduce adailydoseofabout3.5mg/kgbodyweight.Thisdoseis equivalenttothehigherendofthedoserangerecommended fordailytreatmentofhumansatriskforheartattack.We werenotawareofreportsofeffectsofaspirintreatmentin thisdoserangeonlifespaninrodentsatthetimeweinitiatedthisstudy.Toinduceanulcerogenicactivityofaspirin in rodents, a dose 1,000-fold greater than 3.5 mg/kg is typicallyrequired (25) .
NFP was added at 200 mg/kg food to produce a daily doseofabout33mg/kgbodyweight.Instudiesofratsand mice,thisdose,givenorally,hasbeenshowntoprovide protection in a variety of disease models. For example, it diminishedonsetandseverityofdiseaseinamousemodel ofexperimentalautoimmuneencephalomyelitis(26).
4-OH-PBN was added to chow at 315 mg/kg food to produce a daily dose of about 52 mg/kg body weight. Apreliminarystudyinmicegiven4-OH-PBN(10mg/kg/d) orally,beginningat23-24monthsofage,indicatedthatthe treatment increased median survival (maximum survival wasnotdetermined) (27) ;treatmentofratswith37.5mg/kg/d (by drinking water) started at 24.5 months, significantly increasedmeanandmaximumlifespan(by4%-5%) (28 Wefirsttestedmaineffectsandtheirinteractionsinthe full proportional hazards model (including all two-way interactionsandthethree-wayinteraction).Nonsignificant interactionswerethenremovedhierarchically(interactions with the largest p values were removed one at a time) to produce a minimal model; in the DR study, none of the interactionsweresignificantinthefullmodelorinany reducedmodel.
For the NAC study, we first tested effects of treatment andsexandtheirinteraction,asintheDRstudy.Because theinteractionwassignificant,wethenranaseparateanalysis foreachsex.
We also considered statistics for maximum life span becauseinpopulationsthatexperiencesenescence,progressivelymoreinformationabouttheimpactofagingrateson mortalityriskiscontainedinthesurvivaldataasthedata are drawn from progressively older survivorship subsets (2) . One of the best strategies for analysis of maximum life span uses Fisher's Exact Test to evaluate treatment effects on the proportion of treated versus control mice thatsurvivetothelongest-lived10%ofthestudypopula-tion (31). However, this approach requires large sample sizestoobtainreasonablestatisticalpower.Therefore,we loweredthemaximumsurvivalcriteriontothelongest-lived 40%,whichcanprovide,forstudiesoflaboratorymice, even greater power than analysis of total population life span (32) , and which still focuses on a subset of survival datathatcontainsthegreatestinformationaboutagingrates
The nominal logistic model does not take into account censoreddata.Weincludedcensoreddatainouranalysisof maximumlifespaniftheageofthemouseatcensoringwas in the longest-lived 40% because we could unequivocally assignthelifespantothelongest-livedgroup;wedeleted censoreddataiftheageofthemouseatcensoringwasinthe shorter-lived60%becausewecouldnotknowwhichsurvi-vorshipthatmousewouldhavebelongedto.
We analyzed effects of DR or NAC treatment on body weightsusinganalysisofvariance.
Results
Diet Restriction
DR significantly increased life span in both the HET3 andtheCByB6F1population(Table1andFigure1).The relativeresponsetoDRwasthesameforbothstocks,andit didnotdifferbetweenthesexes.Thisconclusionisbased ontheabsenceoftwo-wayinteractionsandthethree-way interaction among sex, genotype, and diet treatment, as indicatedbylikelihoodratiochi-squaretests.Therefore,we combinedthetwogenotypesandsexesfortestsofmaineffects intheproportionalhazardsmodel(Table1andFigure1). Althoughthecombinedgroupsizesfortestsofthemain effectswere32micepergroup(includingcensoreddata), subtleeffectsofsexorgenotypecouldhavebeenmissedin ouranalysis. Forexample,the effect ofDRonmaximum life span (proportion of diet-restricted mice among the longest-lived 40%) was sex dependent (interaction of sex anddietinthenominallogisticmodel,p=.04).Therefore, weseparatedfurtheranalysisofmaximumlifespanbysex. Amongbothmalesandfemales,DRcomparablyincreased maximumlifespan(Figure2,p<.0001,likelihoodratio chi-square test for the nominal logistic model) in both HET3andCByB6F1mice(nosignificantinteractionof stockwithdietforeithersex). Theindividualgroupsizesweretoosmall(14-16miceof eachsexandstockforcontrolandfordiet-restrictedmice) toevaluateeffectsonthelongest-lived10%-acriterionfor analysisofmaximumlifespanrecommendedbyWangetal. (31) .Therefore,toillustratetheeffectsofDRonmaximum lifespanasconventionallydefined,wereportedthelife spansofthelongest-livedtwomiceineachgroup(Table1). DRcomparablyincreasedlifespanforthelongest-lived HET3 and CByB6F1 females by about 1 year, and by somewhat less for the longest-lived HET3 and CByB6F1 males.
Diet-restrictedHET3micealsoweighedlessthancon-trols.Basedonbodyweightdata,thisprotocolappeared togreatlydiminishpostmaturationalgrowth.Forexample, maleweightsat3,8,and16monthswereasfollows:HET3 ad-lib-fedcontrolsaveraged34,45,and47g;diet-restricted HET3malesaveraged26,29,and25g.Again,resultsinthe HET3populationwereverysimilartothoseintheCByB6F1 hybrids(Table1).
N-Acetyl-l-Cysteine
TheeffectofNACtreatmentontotallifespandifferedby sex (interaction of sex and treatment in the proportional hazardsmodel,p= .02,likelihoodratio chi-squaretest); therefore, we analyzed females and males separately. In females,NACtreatmentdidnotsignificantlyaffecttotallife span.Inmales,boththehi-andthelo-NACdosesincreased total life span, although neither was as effective as DR (Figure3).
As with total life span, there was a sex difference in effectsofNAConmaximumlifespan.Forfemales,neither high nor low NAC treatment affected the proportion that survived to the longest-lived 40%. For males, however, thosetreatedwiththehighdoseofNACshowedasignificant increase compared with controls: 11 of 16 treated males versus 2 of 16 control males (p = .0008). Those treated with the low dose of NAC showed a marginal increasecomparedwithcontrols:9of16treatedmaleswere inthelongest-lived40%survivorship,versus4of16ofthe Figure1. Kaplan-Meierplotsofsurvivalcurvescomparingmiceoftwostocks-CByB6F1/JandUM-HET3(HET3),afirst-generationfour-waycross-treated withdietrestriction(DR)oradlib(AL)fed.Atthestartofthestudy,eachgroupconsistedof32mice,16ofeachsex.WeinitiatedDRat4-5weeksofage.Treatment wascontinueduntilmicediedorbecamemoribund.DRincreasedlifespanofbothstocksandbothsexes(p<.0001,likelihoodratiochi-squaretestsinaproportional hazardsmodel).TherelativeresponsetoDRwasthesameforbothstocks,anditdidnotdifferbetweenthesexes(notwo-wayinteractionsorthree-wayinteraction amongstock,sex,anddietintheproportionalhazardsmodel).Datawerecensoredformissingmice(seetheMethodssection)atthefollowingages(days):twofemale HET3ALmice,bothat478days;twofemaleHET3DRmiceat987and1,292days;onemaleCByB6F1ALmouseat460days;twomaleCByB6F1DRmice, bothat1,000days;twomaleHET3ALmiceat92and477days;andonemaleHET3DRmouseat932days.WecensoredthelifespandataforoneHET3AL mouseat266daysduetobitewounds.NodatawerecensoredforfemaleCByB6F1mice.Overall,wecensoreddatafor6ofthe63ALmiceand5ofthe64 diet-restrictedmice. about5gforlo-NACand7gforhi-NAC-duringthefirst 2weeksafterNACtreatmentwasstarted.Therateofweight loss then became much slower, especially in females, but theslowlosscontinueduntilabout900daysofage,when weightsoftheNAC-treatedgroupsweresimilartothoseof diet-restrictedmice(Figure4).Fromweeks4to8ofNAC treatment, we recorded amounts of water consumed per four-mousecage(fourcagespersexandtreatment).NAC treatmentcausedwaterconsumptiontodecline:Forfemale controls,consumptionaveraged4.0mLperdaypermouse, whereas lo-NAC and hi-NAC mice averaged 2.0 and 1.5 mL,respectively;formalecontrols,consumptionaveraged 4.2 mL per day per mouse, whereas lo-NAC and hi-NAC miceaveraged2.0and1.6mL,respectively.
Aspirin, NFP, 4-OH-PBN, and NDGA
Wetestedfouradditionalinterventionsstartingat16-20 monthsofageinHET3females.Aspirin,NFP,4-OH-PBN, andNDGAhadbeentestedpreviouslystartingat4months ofage.Inthatstudy,noneofthetreatmentsincreasedlife span in females. Aspirin and NDGA increased life span slightly, but significantly, only in males (10) . We started theseinterventionslaterinlife(16-18monthsofage)and sawnosignificanteffectonsurvival(Figure5).Weobserved no initial effect of any of the four treatments on body weight;therefore,wecontinuedtomonitorbodyweight only about every 3 months. Mice in all groups, including the control group, continued to gain weight until 20-23 monthsofage.At37monthsofage,whenwestoppedtaking body weights, mice were 28% lighter than their initial weight at 14 months (all groups combined; no significant differenceamongthegroups).Aspirintreatmentmayhave delayed the onset of this age-related weight loss: at 27 monthsofage,aspirin-treatedmicewerestill13%heavier than they were at 14 months, whereas control mice were controlmales(p=.07,likelihoodratiochi-squaretestina nominallogisticmodel).
Figure4comparesbodyweights.WeweighedNACmice ofbothsexesfrequentlybecauseweightsdroppedsuddenly- already8%lighter(p=.03,interactionofageandaspirin treatment,analysisofvariance).Althoughaspirintreatment may retard an aging process that causes late age-related weight loss, we consider this interpretation provisional becauseby31months,andafterward,aspirin-treatedmice weighedthesameascontrolsandtheothertreatedmice.
Discussion
The Genetic Configuration of Mouse Models in Gerontological Research
Becausegerontologistsmuststudytheiranimalmodelsat ageswhensenescenceandage-relateddiseaseinteract,the influence of the genetic configuration itself on disease becomes an important consideration. Homozygous genotypes, such as inbred mouse strains, possess two inherent drawbacks: diminished "physiological buffering" that can limitstressresponse(33)andthelateexpressionofdeleteriousrecessivealleles.Bothcharacteristicscancontributeto susceptibilitytoage-relateddisease,whichcanshortenlife span for reasons unrelated to senescence. In fact, Chai (34)directlydemonstratedthatlifespanofvarioustypesof crossesbetweenthesametwostrains(eg,F1,F2,N2)is inverselycorrelatedwiththedegreeofhomozygosity. F1hybridmicemadefromunrelatedstrainsminimize homozygosity,andtheirrobustnesspermitsnormalagingto proceedandtobemeasured,whileminimizingthecomplicationofdisease-associatedimpairments.AsingleF1stock, however, still represents only a single genotype. Thus, as withaninbredstrain,generalizationmaybelimited.Auseful alternativeisafour-waycrossmodel,typicallycomprising the first-generation offspring of two different F1 hybrids. Whenparentalstrainsareunrelated-aswiththestrainsof theHET3cross-afour-waycrossproducesagenetically highlydiversepopulationthatminimizeshomozygosityand presentsitsallelesinavirtuallyinfiniteassortmentbecause everyunlinkedpolymorphiclocussegregates.Reliabilityis ensured because the genetic makeup of a four-way cross populationcanbereproducedatanytimedirectlyfromthe inbredparentalstrains.Theincreasedgeneticvarianceofa four-waycrossmayrequireagreatersamplesizetomaintainstatisticalpoweratadesiredlevel.Yet,thisadditional expenseisoftenjustifiable,especiallyforpreclinicalstudies, becausetheenhancedreliabilityandbroadapplicabilityof resultscanhelpassurejudiciousdecisionswhendesigning costlyclinicaltrials.
Inthisgroupofstudies,weusedtheHET3four-way crossmicetotesteffectsofsixantiagingtreatmentsonlife span, with the goal of generating results that would have broadapplicabilityforthefieldofgerontology.
Diet Restriction
Although HET3 mice had been well characterized for aging,nopublishedstudieshaddocumentedtheirresponse toDR.DRmarkedlyincreasedbothoverallmeanandmaximumlifespanamongtheHET3mice.Althoughwecannot eliminatethepossibilitythatafewoftheindividualgenotypesinourHET3populationmayhaverespondedtoDR withashortenedlifespan,allthediet-restrictedHET3mice inourstudysurvivedpasttheagewhenthead-lib-fedcontrol HET3 mice began to die; in fact, the first age-related death among diet-restricted HET3 males did not occur until half the ad-lib-fed HET3 males had already died. • Barrows and Roeder (35) 
